M07e细胞
文献支持

M07e细胞

收藏
  • ¥1980
  • EK-Bioscience已认证
  • CD-Y1327
  • 2025年07月13日
    avatar
    品牌商
    11钻石会员
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    M-07e、M-07e、M-07e细胞、M-07e细胞、M-07e人巨细胞白血病细胞

    Cell line name M-07e

    Synonyms M-07E; M-O7e; M07-e; M07e; Mo7e; MO7e; M07E; MO7E

    Accession CVCL_2106

    Resource Identification Initiative To cite this cell line use: M-07e (RRID:CVCL_2106)

    Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: LL-100 blood cancer cell line panel.

    Population: Caucasian.

    Doubling time: 46 +- 12 hours (PubMed=9096695); ~40 hours (DSMZ=ACC-104).

    Omics: Deep exome analysis.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.

    Sequence variations

    Gene fusion; HGNC; 31677; ANO7 + HGNC; 17887; DHDH; Name(s)=ANO7-DHDH (PubMed=31160637).

    Gene fusion; HGNC; 1537; CBFA2T3 + HGNC; 29450; GLIS2; Name(s)=CBFA2T3-GLIS2, ETO2-GLIS2 (PubMed=28109323).

    Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (DepMap=ACH-000602).

    HLA typing Source: DSMZCellDive=ACC-104

    Class I

    HLA-A A*24:02:01,66:01:01

    HLA-B B*13:02:01,49:01:01

    HLA-C C*06:02:01;07:01:01

    Genome ancestry Source: PubMed=30894373

     

    Origin % genome

    African 8.96

    Native American 0

    East Asian, North 0.92

    East Asian, South 0

    South Asian 3.01

    European, North 45.47

    European, South 41.63

    Disease Childhood acute megakaryoblastic leukemia (NCIt: C7972)

    Acute megakaryoblastic leukemia (ORDO: Orphanet_518)

    Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)

    Hierarchy Parent: CVCL_D630 (M-07)

    Children:

    CVCL_RM07 (M-07e/TPO)

    Sex of cell Female

    Age at sampling 6M

    Category Cancer cell line

    STR profile Source(s): CCRID=1101HUM-PUMC000112; DSMZ=ACC-104

     

    Markers:

    Amelogenin X

    CSF1PO 9,10

    D2S1338 19,25

    D3S1358 16,19

    D5S818 11

    D7S820 11

    D8S1179 13 (DSMZ=ACC-104)

    13,16 (CCRID=1101HUM-PUMC000112)

    D13S317 10,11

    D16S539 11

    D18S51 15,20

    D19S433 14,15

    D21S11 30,32.2

    FGA 18,22

    Penta D 9

    Penta E 12,14

    TH01 6,8

    TPOX 8

    vWA 16,18

     

    Run an STR similarity search on this cell line

    PubMed=2273055; DOI=10.1002/jcp.1041450310

    Avanzi G.C., Brizzi M.F., Giannotti J., Brennan A., Yang Y.-C., Pegoraro L., Clark S.C.

    M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3.

    J. Cell. Physiol. 145:458-464(1990)

     

    PubMed=9096695; DOI=10.1038/sj.leu.2400621

    Drexler H.G., Zaborski M., Quentmeier H.

    Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.

    Leukemia 11:541-551(1997)

     

    DOI=10.1016/B978-0-12-221970-2.50457-5

    Drexler H.G.

    The leukemia-lymphoma cell line factsbook.

    (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

     

    PubMed=11414198; DOI=10.1007/s004320000207

    Lahm H., Andre S., Hoeflich A., Fischer J.R., Sordat B., Kaltner H., Wolf E., Gabius H.-J.

    Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.

    J. Cancer Res. Clin. Oncol. 127:375-386(2001)

     

    PubMed=16408098; DOI=10.1038/sj.leu.2404081

    Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.

    JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.

    Leukemia 20:471-476(2006)

     

    PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027

    Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

    The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

    Nature 483:603-607(2012)

     

    PubMed=28109323; DOI=10.1186/s13045-017-0396-0; PMCID=PMC5251306

    Masetti R., Bertuccio S.N., Astolfi A., Chiarini F., Lonetti A., Indio V., De Luca M., Bandini J., Serravalle S., Franzoni M., Pigazzi M., Martelli A.M., Basso G., Locatelli F., Pession A.

    Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.

    J. Hematol. Oncol. 10:26.1-26.5(2017)

     

    PubMed=30285677; DOI=10.1186/s12885-018-4840-5; PMCID=PMC6167786

    Tan K.-T., Ding L.-W., Sun Q.-Y., Lao Z.-T., Chien W., Ren X., Xiao J.-F., Loh X.-Y., Xu L., Lill M., Mayakonda A., Lin D.-C., Yang H.H., Koeffler H.P.

    Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

    BMC Cancer 18:940.1-940.13(2018)

     

    PubMed=30629668; DOI=10.1371/journal.pone.0210404; PMCID=PMC6328144

    Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.

    Screening human cell lines for viral infections applying RNA-Seq data analysis.

    PLoS ONE 14:E0210404-E0210404(2019)

     

    PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675

    Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

    An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

    Cancer Res. 79:1263-1273(2019)

     

    PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103

    Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. 3rd, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.

    Next-generation characterization of the Cancer Cell Line Encyclopedia.

    Nature 569:503-508(2019)

     

    PubMed=31160637; DOI=10.1038/s41598-019-44491-x; PMCID=PMC6547646

    Quentmeier H., Pommerenke C., Dirks W.G., Eberth S., Koeppel M., MacLeod R.A.F., Nagel S., Steube K.G., Uphoff C.C., Drexler H.G.

    The LL-100 panel: 100 cell lines for blood cancer studies.

    Sci. Rep. 9:8218-8218(2019)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由上海酶研生物科技有限公司提供;

    *发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2400
    上海盖宁生物科技有限公司
    2025年12月15日询价
    ¥1400
    上海匹拓生物科技有限公司
    2025年12月18日询价
    ¥900
    安元生物科技(南京)有限公司
    2025年07月14日询价
    ¥1480
    上海酶研生物科技有限公司
    2025年07月09日询价
    ¥2450
    博辉生物科技(广州)有限公司
    2025年12月19日询价
    文献支持
    M07e细胞
    ¥1980